Genmab | 売上原価



Cost Of Sales 変化する 日付
Agios Pharmaceuticals USD 1.26M 477K 2024-12
Almirall EUR 16.73M 73.47M 2024-06
Amarin USD 26.02M 1.3M 2024-09
Amgen USD 3.11B 198M 2024-12
argenx SE USD 72.66M 222.35M 2024-12
AstraZeneca USD 2.24B 484M 2025-03
Bayer EUR 5.72B 633M 2024-12
BioMarin Pharmaceutical USD 136.14M 52.32M 2024-12
Demant DKK 2.75B 1.46B 2024-12
Exelixis USD 19.96M 2.64M 2025-01
Fresenius Medical Care EUR 3.81B 200M 2024-12
Galapagos EUR 13.73M 99.2M 2025-03
Genmab DKK 337M 64M 2024-12
GlaxoSmithKline GBP 1.92B 635M 2025-03
GN Store Nord DKK 1.8B 551M 2025-03
GRIFOLS EUR 1.21B 143.12M 2024-12
Hikma Pharmaceutical USD 813M 39M 2024-06
Insmed USD 26.15M 4.98M 2024-12
Lonza CHF 1.94B 858M 2024-06
Merck EUR 2.32B 197M 2024-12
Novartis USD 3.32B 90M 2024-12
Regeneron Pharmaceuticals USD 265.5M 299.9M 2025-03
Roche Holding CHF 4.13B 393.5M 2024-12
Sanofi EUR 2.89B 618M 2025-03
UCB EUR 425.5M 479.5M 2024-06



Genmab 売上原価 - 現在の値は、過去のデータ、予測、統計、チャートや経済カレンダー - May 2025.